r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

JF

Johanna Friedl-Naderer

Insider · Chief Commercial Officer · DYN

Johanna Friedl-Naderer files insider transactions with the SEC as a chief commercial officer of Dyne Therapeutics (DYN). We hold 6 disclosed purchases and sales filed since 8 March 2022, 4 of them in the last 90 days.

  • Files forDYN
  • Disclosed buys and sells6 in all, 4 in the last 90 days
  • Last disclosure8 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 September 2024 — 8 September 2026Chief Commercial Officer · Dyne Therapeutics (DYN)21 Form 4 lines · source: SEC Form 4
  • Filed 2 March 2022 — 3 March 2023EVP & Chief Operating Officer · Vir Biotechnology (VIR)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

26 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.